NeuralCloud and MyCor360+ Collaborate on Cardiac Monitoring Solution

AI/ML Innovations Inc. subsidiary, NeuralCloud Solutions Inc., has announced a new collaboration with MyCor360+, aimed at integrating its proprietary MaxYield™ ECG signal-processing technology into a developing cardiac monitoring device platform. The partnership seeks to enhance ECG data clarity and functionality through an AI-powered software layer.

MyCor360+ will manage the development of the cardiac device, designed to last 14 days and support automated data transmission. NeuralCloud will provide MaxYield™ to improve ECG signal clarity. This integration intends to support diverse cardiac monitoring applications by refining data accuracy.

This strategic move underscores NeuralCloud's focus on developing partnerships with medical device companies to expand MaxYield's reach. However, the collaboration is in its early stages and subject to regulatory processes. Neither the device nor MaxYield™ has yet achieved FDA clearance.